Disagreement in risk groups for metastatic renal cancer.
Nature reviews. Urology
Nature Publishing Group
MetadataShow full item record
Klatte, T., & Stewart, G. (2019). Disagreement in risk groups for metastatic renal cancer.. Nature reviews. Urology, 16 (6), 332-333. https://doi.org/10.1038/s41585-019-0174-6
In patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan-Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a crucial part of clinical assessment and essential for guiding management. New research has now demonstrated that disagreement in risk-group classification is common and prognostically relevant.
Humans, Carcinoma, Renal Cell, Kidney Neoplasms, Risk Assessment
External DOI: https://doi.org/10.1038/s41585-019-0174-6
This record's URL: https://www.repository.cam.ac.uk/handle/1810/290319